Dr. Richard H. Hope, MD

Dr. Hope practices at Lubbock Dermatology in Lubbock, Texas.

Dr. Hope's NPI, 1457346819, was assigned on September 13, 2005. Dr. Hope graduated from Joe R. & Teresa Lozano Long School of Medicine in 1991. Dr. Hope's Texas license number on file is J2085.

Dr. Hope's primary practice is Lubbock Dermatology, at 3601 22nd St, Lubbock, TX 79410-1309. The practice phone is (806) 796-7193.

Dr. Hope's primary practice is Lubbock Dermatology in Lubbock, Texas. Dr. Hope is also affiliated with Covenant Medical Center. The medical group on file is Lubbock Dermatology and Skin Cancer Center. Dmand AI also links Dr. Hope to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hope practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Hope's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Hope is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Hope's licenses on file in 2 states: Texas and Arkansas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Hope treats.

CMS data shows 12,228 Medicare services from Dr. Hope across 43 procedure codes in 2024, for 1,827 Medicare patients. Medicare paid $626,838 for them. Every service was in an office.

CMS counts 1,827 Medicare patients who saw Dr. Hope in 2024. The largest group is 65 to 74, with 758 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hope's median patient age at 76, with 46% women.

In 2024, Dr. Hope wrote 808 Medicare Part D claims for 437 patients. 98% of them were for generic drugs. CMS names the drug for 725 of them, across 15 drugs with 11 or more claims each, at $14,997 in total drug cost. In 2023, CMS named 852 claims across 18 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Hope for performance year 2024, reported as part of a group. Dr. Hope accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 2,997 procedures of removal of skin lesions by Dr. Hope, more than 99% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Hope, published from 2016 to 2023. 2016 was the busiest year, with 2. The most frequent topics are Skin Neoplasms. Dr. Hope's most frequent co-authors are Amy Rocky Brackeen, MD, Alexander R. Miller, MD and Cloyce L. Stetson, MD.

CMS Open Payments shows 686 general payments to Dr. Hope from 36 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $3,881.

Dmand AI lists 2 awards for Dr. Hope.

Dr. Hope graduated from Joe R. & Teresa Lozano Long School of Medicine in 1991. Dr. Hope is a member of AAD.

Dr. Hope is in network with 17 carriers, including Elevance, Aetna and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.